NuvOx Pharma will target a USD 15m Series A raise in 2014 for its glioblastoma multiforme (GBM) candidate, NVX108,
according to Chief Business Officer David Wilson. (Source: BioPharm Insight) Continue reading
Tag Archives: BioPharm Insight
Regenesis expects sale or final private round next year, CEO says
Regenesis Biomedical profiled in BioPharm Insight…
Continue reading
Illumina, Qiagen set to drive adoption of NGS testing for clinical use with new platforms (BioPharm Insight)
- Next-generation sequencing could help find answers behind misunderstood pediatric diseases
- Results are now available within a day or two
- Costs of genomic sequencing have dropped dramatically
Next-generation sequencing could emerge as new standard of testing in cancer research and care – analysis from BioPharm Insight
Need for more trained biostatisticians to understand genetic data
CUSTOM study is first completed prospective trial using genetic analysis alone to assign cancer treatment
TGen conducting advanced melanoma study evaluating genomic-sequencing guided treatment and outcomesContinue reading